Toggle light / dark theme

Health Care.

As the U.S. Struggles With a Stillbirth Crisis, Australia Offers a Model for How to Do Better.

Australia has emerged as a global leader in the effort to lower the number of babies that die before taking their first breaths. It’s an approach that could benefit America, which lags behind other wealthy nations in reducing stillbirths.

India has used traditional methods of agriculture for generations, but with 1.4 billion people now dependant on the crops farmers produce, some are turning to technology to boost productivity and profit.

For example on one vineyard, sensor devices are being used to check weather and soil health.

Artificial intelligence (AI) can then figure out when it’s time to water the crops, add fertiliser and tackle pests.

Nitin Patil, who works at the vineyard, says the AI advice has helped \.

FactorBioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell Therapies Read the latest here.


Factor Bioscience Inc. announced the award of a U.S. Department of Defense grant to develop next-generation cell therapy candidates using Factor’s patented mRNA, cell-reprogramming, and gene-editing technologies. The project will be led by Factor’s Co-Founder and Chief Technology Officer, Dr. Christopher Rohde.

Under the award, Factor will generate the first scalable cell therapy specifically targeting muscle inflammation in DMD patients. To carry out the work, Factor will utilize its extensively patented technologies for engineering cells, including methods for reprogramming and gene-editing cells using mRNA.

The award is sponsored by the Office of the Assistant Secretary of Defense for Health Affairs, through the Duchenne Muscular Dystrophy Research Program, which is endorsed by the Department of Defense. The award will fund development activities for up to five years.

In a preclinical study, researchers led by City of Hope have discovered that a type of immune cell in the human body, known to be important for allergy and other immune responses, can also attack cancer. The cells, called human type 2 innate lymphoid cells (ILC2s), can be expanded outside of the body and applied in larger numbers to overpower a tumor’s defenses and eliminate malignant cells in mouse models with cancer.

The findings are published in Cell in an article titled, “Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.”

“The City of Hope team has identified human ILC2 cells as a new member of the cell family capable of directly killing all types of cancers, including blood cancers and solid tumors,” said Jianhua Yu, PhD, a professor in the department of hematology and hematopoietic cell transplantation at City of Hope and the study’s senior author. “In the future, these cells could be manufactured, preserved by freezing, and then administered to patients. Unlike T cell-based therapies, such as CAR T cells, which necessitate using the patient’s own cells due to their specific characteristics, ILC2s might be sourced from healthy donors, presenting a distinct potential therapeutic approach as an allogeneic and ‘off-the-shelf’ product.”

One approach to AI uses a process called machine learning. In machine learning, a computer model is built to predict what may happen in the real world. The model is taught to analyze and recognize patterns in a data set. This training enables the model to then make predictions about new data. Some AI programs can also teach themselves to ask new questions and make novel connections between pieces of information.

“Computer models and humans can really work well together to improve human health,” explains Dr. Grace C.Y. Peng, an NIH expert on AI in medicine. “Computers are very good at doing calculations at a large scale, but they don’t have the intuitive capability that we have. They’re powerful, but how helpful they’re going to be lies in our hands.”

Researchers are exploring ways to harness the power of AI to improve health care. These include assisting with diagnosing and treating medical conditions and delivering care.

We don’t have a cure for Parkinson’s disease yet, but a recently discovered mutation in mitochondrial DNA that seems to protect the body against the condition could one day point the way to one. Discovered in a small protein called SHLP2, the genetic variant is relatively rare – found in just 1 percent of Europeans. Yet an analysis of the health records of 16,167 people led by researchers from the University of Southern California (USC) suggests…

“The bottom-line finding is that cannabis before exercise seems to increase positive mood and enjoyment during exercise, whether you use THC or CBD. But THC products specifically may make exercise feel more effortful,” said Dr. Laurel Gibson.


How does cannabis influence workouts? Does it serve as a performance enhancer or in other ways? This is what a recent study published in Sports Medicine hopes to address, as a team of researchers from the University of Colorado Boulder (CU Boulder) and the University of Colorado Anschutz Medical Campus investigated how cannabis influences exercise workouts and regimens, specifically pertaining to the exercise performance. This study comes almost a decade since Colorado legalized the sale of recreational marijuana and holds the potential to help researchers and the public better understand cannabis’ role in our everyday lives.

For the first-of-its-kind study that started in 2021, the researchers recruited 42 participants who were consistent cannabis users ages 21 to 39 to ascertain their responses to exercise after using cannabis and in a controlled laboratory setting. In the end, the participants reported increased enjoyment and “runner’s high” characteristics while also reporting greater levels of exertion during their exercise regimen. Additionally, the participants reported the following when the researchers asked them why they combine cannabis with their workout routines: 90.5 percent said it increases enjoyment, 69 percent said it reduces pain, 59.5 percent said it increases focus, 57.1 percent said it increases motivation, 45.2 percent stated they perceived that it speeds up time, and 28.6 percent said it improves their performance.

The microbiome has a profound influence on our health, but exactly how our resident bacteria wield their power is still unclear. A type of T cell appears to provide some answers for gastrointestinal health, a study of the mouse microbiome finds.

The study, appearing in the journal Immunity, found that when friendly, commensal microbes set up residence inside the gut, their host produces T cells that maintain the health of the gut by counteracting .

The finding could lead to new treatments for inflammatory bowel diseases (IBD).